PARP inhibitors: what we know and what we have yet to know
- PMID: 20187323
PARP inhibitors: what we know and what we have yet to know
Comment on
-
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer.Oncology (Williston Park). 2010 Jan;24(1):55-62. Oncology (Williston Park). 2010. PMID: 20187322 Review.